K
Karl Thoma
Researcher at Ludwig Maximilian University of Munich
Publications - 36
Citations - 484
Karl Thoma is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Dosage form & Dissolution testing. The author has an hindex of 9, co-authored 36 publications receiving 473 citations.
Papers
More filters
Journal ArticleDOI
Influence of aqueous coatings on the stability of enteric coated pellets and tablets.
Karl Thoma,Karoline Bechtold +1 more
TL;DR: When applied to vitamin B2 tablets, Eudragit L 100-55, Opadry enteric (PVAP) and Aqoat (HPMCAS) proved to be quite stable aqueous enteric coatings, whereas cellulose acetate phthalate CAP or cellulOSE acetate trimellitate CAT coatings as ammonia-neutralized aQueous solution or as water-based pseudolatex Aquateric were unstable when stored under stress conditions.
Journal ArticleDOI
Retardation of weakly basic drugs with diffusion tablets
Karl Thoma,T. Zimmer +1 more
TL;DR: In the case of noscapine HCl, an improvement in release was achieved over the pH range 1.2 (first hour) to 7.5 (eighth hour) that depends on the type and amount of acid added as mentioned in this paper.
Journal ArticleDOI
The pH-independent release of fenoldopam from pellets with insoluble film coats
Karl Thoma,Iris Ziegler +1 more
TL;DR: In this paper, various ratios of succinic acid to fenoldopam mesylate, ranging from 0:1 to 18:1, were incorporated in pellets and coated with 15-12% Surelease.
Journal ArticleDOI
The influence of formulation and manufacturing process on the photostability of tablets.
Wolfgang Aman,Karl Thoma +1 more
TL;DR: Investigations of various formulation and manufacturing parameters were done with tablets containing nifedipine and molsidomine as highly light sensitive drugs, and photostability changes up to 10% were registered.
Journal ArticleDOI
Photostabilization of drugs in dosage forms without protection from packaging materials
Karl Thoma,R. Klimek +1 more
TL;DR: The principle of photoprotection by spectral overlapping is described, which is not only feasible for drugs in solution, but also effective in other dosage forms such as tablets or topical preparation.